JB Chemicals & Pharmaceuticals Limited — Updates, 11-05-2026: Press Release

JB Pharma's Q4 FY26 saw revenue at 904 Cr (-5% YoY) and net profit at 101 Cr (-30% YoY), impacted by post-acquisition integration. FY26 revenue rose 6% to 4,148 Cr. Management expects recovery from Q1, citing temporary impacts and improving margins from cost synergies.